Bio

Mr. Meyers is a Managing Director for VelocityHealth Securities, and he is focused on the capital markets in various health care sectors, including the pharmaceuticals. Mr. Meyers is a seasoned veteran of Wall Street, having worked in the financial securities industry for over 25 years. He most recently worked as the CFO of Legacy BioPharm, where he led the execution of their acquisition of WraSer Pharmaceuticals and Xspire Pharma. Additionally, he has worked in institutional equities at several bulge bracket Investment Banks including Bear Stearns, Credit Suisse First Boston, UBS, and Deutsche Bank. He was a partner and Managing Director at CRT Capital, a boutique investment banking firm, where he headed the equity trading desk overseeing proprietary and institutional facilitation trading, while coordinating with investment banking on IPO and follow on offerings. Mr. Meyers has expertise in discovering, evaluating, negotiating and monetizing various types of financial assets. His capital markets experience provides comprehensive knowledge in modeling, capital raising, and structuring financial instruments. Mr. Meyers received his BA degree from Providence College. Mr. Meyers holds the Series 24, 55, 7 & 63 Licenses.